FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER

• Egile Nagusiak: T. Christopher Bond (Egilea), Rich Mutell (Egilea), Stephen Wang (Egilea), Enrique Poradosu (Egilea), Robert Niecestro Tracy (Egilea)
• Formatua: Liburua
• Argitaratua: The Korean Society of Nephrology, 2012-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Patients with end-stage renal disease (ESRD) often experience secondary bone and mineral disorder requiring treatment with phosphate-binder (PB) medications, vitamin D sterols, and calcimimetics. Ferric citrate is an oral, iron-based PB in clinical development that has been shown to reduce serum pho...